Polymorphism plays a vital role in the development of pharmaceutical ingredients. Polymorphs of active pharmaceutical ingredients (APIs) have always drawn attention in view of their physicochemical and intellectual property. Sofosbuvir (commercially marketed as Sovaldi by Gilead Sciences, USA) is one of the best-known and most prescribed drug for chronic hepatitis C, genotypes 1, 2, 3, 4, 5, and 6, usually in combination with other medications depending on the specific genotype.
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Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate. It is a high revenue API ($24.9 billion in 2014) since was first commercialized in 2013. Sofosbuvir is known to exhibit polymorphism [1] However, till date no report on crystal structures of Sofosbuvir polymorphs were known in literature. We report here for the first time crystal structure analysis of Sofosbuvir polymorphs Form1, Form 7 and Form 8. Form 1 and form 7 are crystallizes in monoclinic crystal (P21) system while form 8 get crystallized into orthorhombic crystal system with non-centrosymmetric space group P212121. The crystal structure analysis reveals Sofosbuvir exhibits conformational polymorphism. Conformational flexibility around phosphate group leads to different types of hydrogen bonding networks dominated by N-H…O, O-H…O, C-H… O interactions. Further, the inability to grow the single crystals of Form 6 suitable for single crystal X-ray diffraction made us to explore 3D precession electron diffraction tomography[2] and rietveld method [3] for deriving the crystal structure. In this work we discuss for the first time, structural features of Sofosbuvir polymorphs and application of electron diffraction technique for crystal structure determination of Form 6.
